Safety and Performance Evaluation of the SAVA Continuous Glucose Monitor for Effective Glucose Detection
NCT: NCT07679347 · NOT_YET_RECRUITING
Brief Summary
The goal of this clinical trial is to evaluate the safety and performance of the SAVA Continuous Glucose Monitor across glucose ranges over a period of 15-day wear in adults over 18 years of age with Type 1 Diabetes. This is a pilot study, so the main purposes are to collect preliminary data for future studies, assess comfort and safety, and explore the accuracy of the CGM against references and benchmarks.
Frequently Asked Questions
What is Safety and Performance Evaluation of the SAVA Continuous Glucose Monitor for Effective Glucose Detection?
Safety and Performance Evaluation of the SAVA Continuous Glucose Monitor for Effective Glucose Detection is a clinical trial registered under NCT07679347. Current status: NOT_YET_RECRUITING.
What is the status of NCT07679347?
The current status of NCT07679347 (Safety and Performance Evaluation of the SAVA Continuous Glucose Monitor for Effective Glucose Detection) is: NOT_YET_RECRUITING.
When did Safety and Performance Evaluation of the SAVA Continuous Glucose Monitor for Effective Glucose Detection start?
Safety and Performance Evaluation of the SAVA Continuous Glucose Monitor for Effective Glucose Detection started on 2026-08.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.